Patient expectations are better for immunotherapy than traditional chemotherapy for cancer.
Andreas IhrigJenniffer RichterCarsten GrüllichLeonidas ApostolidisPeter HorakMatthias VillalobosMiriam GrappHans Christoph FriederichImad MaatoukPublished in: Journal of cancer research and clinical oncology (2020)
The lack of understanding of ICIs should be improved by activities to increase the knowledge of ICI patients and the general population. In contrast to CT, ICIs invoked fewer negative associations with efficacy and toxicity. Therefore, attention should be paid to risk awareness when educating patients. (Clinical trial registration number: DRKS00011868) Trial Registration: German clinical trials register, www.germanctr.de , number DRKS00011868.
Keyphrases
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- prognostic factors
- randomized controlled trial
- phase ii
- phase iii
- oxidative stress
- computed tomography
- peritoneal dialysis
- radiation therapy
- squamous cell carcinoma
- magnetic resonance imaging
- case report
- patient reported outcomes
- working memory
- lymph node metastasis